These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12588012)

  • 21. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A; Aguiman L; Adlawan S; Baring E; Quirante O; Suchi M; Endo S; Fujiki A; Mori T
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany.
    Kubica T; Rüsch-Gerdes S; Niemann S
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1107-13. PubMed ID: 15455596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factors affecting incidence of tuberculosis in Diyarbakir].
    Tanrikulu AC; Abakay A; Abakay O; Alp A
    Tuberk Toraks; 2007; 55(1):18-23. PubMed ID: 17401790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.
    Singla R; Khan N; Al-Sharif N; Ai-Sayegh MO; Shaikh MA; Osman MM
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):74-9. PubMed ID: 16466041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death.
    Chiang CY; Lee JJ; Yu MC; Enarson DA; Lin TP; Luh KT
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):105-11. PubMed ID: 19105887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
    Sharma S; Sarin R; Khalid UK; Singla N; Sharma PP; Behera D
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):74-80. PubMed ID: 18173881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and effectiveness of a public-private mix project for improved TB control in Delhi, India.
    Arora VK; Sarin R; Lönnroth K
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1131-8. PubMed ID: 14677887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
    Talay F; Kumbetli S; Altin S
    Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for death during tuberculosis treatment in Orel, Russia.
    Dewan PK; Arguin PM; Kiryanova H; Kondroshova NV; Khorosheva TM; Laserson K; Kluge H; Jakubowiak W; Wells C; Kazionny B
    Int J Tuberc Lung Dis; 2004 May; 8(5):598-602. PubMed ID: 15137537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis-related deaths in Queensland, Australia, 1989-1998: characteristics and risk factors.
    Walpola HC; Siskind V; Patel AM; Konstantinos A; Derhy P
    Int J Tuberc Lung Dis; 2003 Aug; 7(8):742-50. PubMed ID: 12921150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally.
    Radilla-Chávez P; Laniado-Laborín R
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):289-92. PubMed ID: 17352094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
    Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
    Crudu V; Arnadottir T; Laticevschi D
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.